JAVIER MARTINEZ: Open Payments
NPI 1225162068 · EDINBURG, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,108 in 55 payments from 12 companies in 2025. Trend: 2023 $596 · 2024 $793 · 2025 $1,108
Food & beverage: $1,107Education: $1
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 5 | $297 |
| Alkermes, Inc. | 21 | $182 |
| Teva Pharmaceuticals USA, Inc. | 16 | $165 |
| Nalu Medical, Inc. | 1 | $131 |
| Otsuka America Pharmaceutical, Inc. | 4 | $97 |
| Davol Inc. | 1 | $89 |
| ABBVIE INC. | 2 | $46 |
| Janssen Pharmaceuticals, Inc | 1 | $24 |
| E.R. Squibb & Sons, L.L.C. | 1 | $23 |
| Neurocrine BioSciences, Inc. | 1 | $21 |
Products named: FANAPT, ARISTADA, UZEDY, Nalu Neurostimulation System, Progel Applicator Spray Tips, REXULTI, VRAYLAR, INVEGA SUSTENNA.
Industry payments across TX — which companies pay providers there.
